2023Gaceta Médica de MéxicoOpen access

Polycythaemia vera

Raúl Martínez-Castro, Gilberto Barranco-Lampón, Luara L. Arana-Luna, José L. Álvarez-Vera, Flavio Rojas-Castillejos, Rosalinda Peñaloza-Ramírez, Adrián A. Carballo‐Zarate, Irma Olarte-Carrillo, Jaime Israel-García Minamy, Javier López‐Salazar, Juan José Cervantes Navarrete, Arturo Espinosa-Partida, Yanet Ventura-Enríquez, Josué I. Ruiz-Contreras, Oyuky G. Aguirre-Reyes, Irene Anaya-Cuéllar, Jocelyn Aguilar-Luévano, Hugo Francisco Díaz-Ramírez, Wilfrido Herrera-Olivares, José Antonio Aguilar-Hidalgo, Luisa Ma Alcívar-Cedeño, Álvaro Hernández-Caballero, Lourdes Elena Galaz-Cordero, José A. de la Peña-Celaya, Pamela E. Báez-Islas, Ramón Alberto Bates-Martín, Ana Ma de la Luz Cano-León, Ma. Eugenia Espitia-Ríos, Diego Barbosa, Javier Morales-Adrián, Martín Jacobo Pacheco, Nancy Delgado-López, Yvette Neme-Yunes, Alba Edna Moralws-Hernández, Aldo Mújica-Martínez, Alejandra B. Pérez-Lizardi, Karen D. Pérez-Gómez, Gabriel Barragán-Ibáñez, Adolfo Martínez, Karen Flores-Ordúñez, Paulina Ramírez-Hoyos, Ma de Los Ángeles Rosales-López, Brenda L. Acosta‐Maldonado, Marco A. Jiménez-Ochoa, Katheryn B. Garzón-Velásquez, Eleazar Hernández-Ruiz, Bosco Martín McNally-Guillén, Erick E. Saucedo-Montes, Carolina Aguilar-Andrade, Cindy Lissette Vivas-Arteaga, Lidia V. Guerra-Alarcón, Andrea I. Milán-Salvatierra, Dafne Itzel Campa-Monroy, Xóchitl Cota-Rangel, Patricia Estrada-Domínguez, Alinka Socorro García-Camacho, Carolina García-Castillo, Luisa I. Banda-García, Vania Rodríguez-Sánchez, Luis Antonio Meillón‐García, Elizabeth Urbina-Escalante, Mario A. Martínez-Ramírez, Sergio José Loera-Fragoso, Jorge Martínez-Coronel, Nidia Zapata-Canto, Sue C. Gómez Cortés, Jesús Emanuel Medina-Coral, Liliana Mójica-Balderas, Juan Manuel Pérez-Zúñiga, Fernando Jacobo Pérez, José L. López-Arroyo, Juan F. Zazueta-Pozos, Eduardo Romero-Martínez, Hilda Romero-Rodelo, Ana Laura Tapia-Enríquez, Emely J. Soriano-Mercedes, Óscar Salazar-Ramírez, Shendel P. Vilchis-González, Fredy Tepepa-Flores, Martha Alvarado‐Ibarra

Open full text 0 citations

Abstract

Polycythemia vera (PV) is mainly characterized by erythrocytosis, thrombotic and hemorrhagic predisposition, a variety of symptoms, and cumulative risks of fibrotic progression and/or leukemic evolution over time. The diagnosis is made based on the 2016 WHO criteria. The treatment of PV focuses on rapidly reducing the erythrocyte mass, either by means of phlebotomies or with cytoreductive treatment, and the reduction of thrombotic risk by correcting cardiovascular risk factors and the use of platelet antiaggregants.

Open-access reader

About this research paper

What this paper is about

Polycythemia vera (PV) is mainly characterized by erythrocytosis, thrombotic and hemorrhagic predisposition, a variety of symptoms, and cumulative risks of fibrotic progression and/or leukemic evolution over time. The diagnosis is made based on the 2016 WHO criteria. The treatment of PV focuses on rapidly reducing the erythrocyte mass, either by means of phlebotomies or with cytoreductive treatment, and the reduction of thrombotic risk by correcting cardiovascular risk factors and the use of platelet antiaggregants.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Polycythemia vera (PV) is mainly characterized by erythrocytosis, thrombotic and hemorrhagic predisposition, a variety of symptoms, and cumulative risks of fibrotic progression and/or leukemic evolution over time. The diagnosis is made based on the 2016 WHO criteria. The treatment of PV focuses on rapidly reducing the erythrocyte mass, either by means of phlebotomies or with cytoreductive treatment, and the reduction of thrombotic risk by correcting cardiovascular risk factors and the use of platelet antiaggregants.

Key concepts: Polycythaemia, Polycythemia vera, Phlebotomy, Medicine, Internal medicine, Gastroenterology

Related papers

Back to paper searchBrowse research topicsOriginal source
Polycythaemia vera — Research Paper | ScholarLens